Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Nutr Metab Cardiovasc Dis. 2015 Apr 25;25(8):780–786. doi: 10.1016/j.numecd.2015.04.005

TABLE 3.

MULTIVARIABLE LINEAR ASSOCIATIONS BETWEEN TOTAL ADIPONECTIN AND NT-proBNP

OUTCOME: Visit 3 NT-Pro BNP (pg/ml)
Adipokine Model 1 Model 2 Model 3*
Estimate p-value Estimate p-value Estimate p-value
Adiponectin (1-SD) 21.16 < 0.01 21.0 < 0.01 14.0 < 0.01      
Adiponectin Quartiles      
-Q2* 1.16 0.03 1.16 0.06 1.15 0.09      
-Q3* 1.40 <0.01 1.41 <0.01 1.42 <0.01      
-Q4* 1.74 <0.01 1.65 <0.01 1.58 <0.01      
OUTCOME: NT-Pro BNP Change from Visit 1 to Visit 3 (pg/ml)
Adipokine Model 1 Model 2 Model 3 Model 4**
Estimate p-value Estimate p-value Estimate p-value Estimate p-value
Adiponectin (1-SD) 16.9 < 0.01 16.3 < 0.01 19.8 < 0.01 23.9 < 0.01
Adiponectin Quartiles
-Q2 −7.9 0.55 15.0 0.35 7.7 0.65 −5.0 0.77
-Q3 13.1 0.34 14.8 0.37 13.9 0.43 18.9 0.27
-Q4 34.4 0.02 27.6 0.13 31.9 0.11 43.0 0.03

1-SD = 1-standard deviation increment of total adiponectin (13.1 μg/ml), Parameter estimate is a percent (i.e. 1.16 = 16% higher than reference)

*

R2 (1-SD) = 0.36, R2 (Quartiles) = 0.37;

**

R2 = 0.09, R2 = 0.09

Model 1: age, sex and race

Model 2: Model 1 + height, visceral and subcutaneous fat areas, dyslipidemia, diabetes, smoking, hypertension, eGFR, leptin, aldosterone & renin

Model 3: Model 2 + left ventricular mass and left ventricular ejection fraction

Model 4: Model 3 + NT-proBNP (visit 1 value)